Publication Name	World Journal of Gastroenterology
Manuscript ID	13185
Country	China

Received	2014-08-11 08:53
Peer-Review Started	2014-08-11 15:34
To Make the First Decision	2014-08-27 19:10
Return for Revision	2014-08-28 11:22
Revised	2014-09-15 12:59
Second Decision	2014-11-10 16:38
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-11-19 09:32
Articles in Press	2014-11-19 09:46
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-12-16 14:16
Typeset the Manuscript	2015-02-07 12:37
Publish the Manuscript Online	2015-02-28 17:07

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Prospective Study
Article Title	Long-term outcome of infliximab combined with surgery for perianal fistulizing Crohn's disease
Manuscript Source	Unsolicited Manuscript
All Author List	Bo-Lin Yang, Yu-Gen Chen, Yun-Fei Gu, Hong-Jin Chen, Gui-Dong Sun, Ping Zhu and Wan-Jin Shao
Funding Agency and Grant Number
Corresponding Author	Bo-Lin Yang, MD, Department of Colorectal Surgery, the Affiliated Hospital of Nanjing University of Chinese Medicine, No. 155 Hanzhong Road, Nanjing 210029, Jiangsu Province, China. blyang1971@163.com
Key Words	Infliximab; Surgery; Crohn’s disease; Anal fistula
Core Tip	Infliximab (IFX) combined with surgery for the treatment of Crohn’s disease (CD) anal fistula has significant effects, improves the clinical cure rate, and shortens the fistula healing time. Our findings indicate that IFX combined with surgical treatment is the reasonable treatment for anal fistulas in CD and that the normal ranges of CD activity index and C-reactive protein do not mean the endoscopic healing.
Publish Date	2015-02-28 17:07
Citation	Yang BL, Chen YG, Gu YF, Chen HJ, Sun GD, Zhu P, Shao WJ. Long-term outcome of infliximab combined with surgery for perianal fistulizing Crohn's disease. World J Gastroenterol 2015; 21(8): 2475-2482
URL	http://www.wjgnet.com/1007-9327/full/v21/i8/2475.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i8.2475

Full Article (PDF)	WJG-21-2475.pdf
Full Article (Word)	WJG-21-2475.doc
Manuscript File	13185-Review.doc
Answering Reviewers	13185-Answering reviewers.pdf
Copyright License Agreement	13185-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	13185-Language certificate.pdf
Peer-review Report	13185-Peer review(s).pdf
Scientific Misconduct Check	13185-CrossCheck.jpg
Scientific Editor Work List	13185-Scientific editor work list.pdf